Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of anti-angiogenesis agents for the treatment of metastatic and recurrent cervical cancer.

This is a protocol.

Health topics:

Published:

8 May 2020

Authors:

Rizzuto I, Otter SJ, Bharathan R, Stewart A

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Rizzuto I, Otter SJ, Bharathan R, Stewart A. Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD013605. DOI: 10.1002/14651858.CD013605.